| WS6 |
WS6 |
1421227-53-3 |
| Mutant EGFR inhibitor |
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 |
1421373-62-7 |
| Doxercalciferol-D3 |
度骨化醇-D3 |
1217448-46-8 |
| PTC-209 (hydrobroMide) |
PTC-209HBR |
1217022-63-3 |
| Btk inhibitor 1 |
1412418-47-3 |
1412418-47-3 |
| GSK J2 |
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1394854-52-4 |
| Oclacitinib Maleate(PF-03394197) |
马来酸奥拉替尼 |
1208319-27-0 |
| BenzenesulfonaMide, 3-chloro-2-Methyl-N-[5,6,7,8-tetrahydro-2-[(2-phenylethyl)aMino]-6-(phenylMethyl)pyrido[4,3-d]pyriMidin-4-yl]- |
3-氯-2-甲基-N-[5,6,7,8-四氢-2-[(2-苯基乙基)氨基]-6-(苯基甲基)吡啶并[4,3-D]嘧啶-4-基]苯磺酰胺 |
1208123-85-6 |
| Isoforsythiaside |
异连翘酯苷 |
1357910-26-9 |
| BMN 673 (8R,9S) |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氢-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
| AM-679 |
AM-679 |
1206880-66-1 |
| N-[2-[[(2,3-Difluorophenyl)methyl]thio]-6-[[(1S,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-1-azetidinesulfonamide |
N-[2-[[(2,3-二氟苯基)甲基]硫基]-6-[[(1S,2R)-2,3-二羟基-1-甲基丙基]氨基]-4-嘧啶基]-1-氮杂环丁烷磺酰胺 |
1204707-73-2 |
| Presatovir |
GS-5806 |
1353625-73-6 |
| CX6258(HCL) |
CX-6258HCL |
1353859-00-3 |
| T338C Src-IN-1 |
CS-2101 |
1351926-90-3 |
| T338C Src-IN-2 |
1351927-00-8 |
1351927-00-8 |
| NMS-P715 |
NMS-P715 |
1202055-34-2 |
| Pradefovir Mesylate |
1202000-62-1 |
1202000-62-1 |
| AC710 |
N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺 |
1351522-04-7 |
| GNE 220 |
1199590-75-4 |
1199590-75-4 |
